Promising anticancer therapy: combination of immune checkpoint inhibitors and molecular-targeted agents

被引：6
|
作者：
Sakurai, Toshiharu [1 ]
Nishida, Naoshi [1 ]
Kudo, Nishida Masatoshi [1 ]
机构：
[1] Kindai Univ, Dept Gastroenterol & Hepatol, Fac Med, 377-2 Ohno Higashi, Osaka 5898511, Japan
来源：
HEPATOBILIARY SURGERY AND NUTRITION | 2020年 / 9卷 / 06期
关键词：
COMPENSATORY PROLIFERATION; HEPATOCELLULAR-CARCINOMA; T-CELL; SORAFENIB; ACTIVATION; CANCER; DEATH;
D O I：
10.21037/hbsn.2020.03.04
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：777 / 779
页数：3
相关论文
共 50 条
  • [1] Immune checkpoint inhibitors: a promising anticancer therapy
    Singh, Sima
    Hassan, Daniel
    Aldawsari, Hibah M.
    Molugulu, Nagashekhara
    Shukla, Rahul
    Kesharwani, Prashant
    DRUG DISCOVERY TODAY, 2020, 25 (01) : 223 - 229
  • [2] JAK Inhibitors: A Promising Molecular-targeted Therapy in Dermatomyositis
    Landon-Cardinal, Oceane
    Guillaume-Jugnot, Perrine
    Bolko, Lois
    Toquet, Segolene
    Rigolet, Aude
    Hervier, Baptiste
    Champtiaux, Nicolas
    Vautier, Mathieu
    Benveniste, Olivier
    Allenbach, Yves
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [3] Hepatic Resection for Hepatocellular Carcinoma in the Era of Molecular-targeted Agents and Immune Checkpoint Inhibitors in Japan
    Taketomi, Akinobu
    JMA JOURNAL, 2021, 4 (03): : 241 - 245
  • [4] Molecular-targeted agents combination therapy for cancer: Developments and potentials
    Li, Feifei
    Zhao, Changqi
    Wang, Lili
    INTERNATIONAL JOURNAL OF CANCER, 2014, 134 (06) : 1257 - 1269
  • [5] Preclinical evaluation of molecular-targeted anticancer agents for radiotherapy
    Krause, Mechthild
    Zips, Daniel
    Thames, Howard D.
    Kummermehr, Johann
    Baumann, Michael
    RADIOTHERAPY AND ONCOLOGY, 2006, 80 (02) : 112 - 122
  • [6] Combination Therapy with Immune Checkpoint Inhibitors and Histone Deacetylase Inhibitors or Alkylating Agents
    Joerger, Markus
    Koster, Kira -Lee
    Janik, Tomas
    de Jong, Floris A.
    CANCER MANAGEMENT AND RESEARCH, 2024, 16 : 855 - 869
  • [7] Considerations for the combination of anticancer vaccines and immune checkpoint inhibitors
    Strauss, Julius
    Madan, Ravi A.
    Gulley, James L.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2016, 16 (07) : 895 - 901
  • [8] Anti-angiogenic Agents in Combination With Immune Checkpoint Inhibitors: A Promising Strategy for Cancer Treatment
    Song, Yuxiao
    Fu, Yang
    Xie, Qi
    Zhu, Bo
    Wang, Jun
    Zhang, Bicheng
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [9] Toward Personalized Cancer Therapy with Oral Molecular-targeted Agents
    Yamaguchi, Hiroaki
    Takasaki, Shinya
    Kikuchi, Masafumi
    Kawasaki, Yoshihide
    Arai, Yoichi
    Mano, Nariyasu
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2019, 139 (06): : 911 - 915
  • [10] Combination of immune-checkpoint inhibitors and targeted therapies for melanoma therapy: The more, the better?
    Maximilian Haist
    Henner Stege
    Michael Kuske
    Julia Bauer
    Annika Klumpp
    Stephan Grabbe
    Matthias Bros
    Cancer and Metastasis Reviews, 2023, 42 : 481 - 505
12345